DeutschEnglishEspañolFrançaisItaliano日本語Portuguêsالعربية한국어Русский

Member of:

EphMRA Associate MemberEphMRA Associate Member

Online Monitors (OMO)

42 market research is operating the Online Monitor (OMO) - a powerful patient tracker.

Unlike other "snap shot" monitors, the OMO is the continuous documentation of every patient being treated for the following indications:-

Breast Cancer Head and Neck Tumours

Non-Small Cell Lung Cancer (NSCLC)

Rheumatoid Arthritis
Colorectal Cancer Diabetes
Prostate Cancer Haematological Diseases                     
Non-Hodgkin Lymphoma (NHL) Nephrological Diseases
Renal Carcinoma Cardiovascular Diseases
Ovarian Cancer CNS Diseases
Brain Tumours HIV

The OMO is developed, designed, programmed, hosted and operated exclusively by 42 market research

For a more detailed overview on the OMO please click here.